These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8792879)

  • 1. Reduced hypoxic chemosensitivity in partially paralysed man. A new property of muscle relaxants?
    Eriksson LI
    Acta Anaesthesiol Scand; 1996 May; 40(5):520-3. PubMed ID: 8792879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atracurium and vecuronium block nicotine-induced carotid body chemoreceptor responses.
    Jonsson M; Kim C; Yamamoto Y; Runold M; Lindahl SG; Eriksson LI
    Acta Anaesthesiol Scand; 2002 May; 46(5):488-94. PubMed ID: 12027840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a vecuronium-induced partial neuromuscular block on hypoxic ventilatory response.
    Eriksson LI; Sato M; Severinghaus JW
    Anesthesiology; 1993 Apr; 78(4):693-9. PubMed ID: 8096684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine potentiates nondepolarizing neuromuscular relaxants in a primate.
    Tsai SK; Lee C
    Anesth Analg; 1989 Jan; 68(1):5-8. PubMed ID: 2562910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of isoflurane and sevoflurane on the magnitude and time course of neuromuscular block produced by vecuronium, pancuronium and atracurium.
    Vanlinthout LE; Booij LH; van Egmond J; Robertson EN
    Br J Anaesth; 1996 Mar; 76(3):389-95. PubMed ID: 8785139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Train-of-four fade during onset of neuromuscular block with nondepolarising neuromuscular blocking agents.
    Gibson FM; Mirakhur RK
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):204-6. PubMed ID: 2567104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of atracurium, vecuronium and pancuronium during sufentanil anesthesia for coronary artery bypass.
    Waldmann CS; Wark KJ; Sebel PS; Feneck RO
    Acta Anaesthesiol Scand; 1986 Jul; 30(5):351-6. PubMed ID: 2876575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans.
    Rimaniol JM; Dhonneur G; Sperry L; Duvaldestin P
    Anesth Analg; 1996 Oct; 83(4):808-13. PubMed ID: 8831326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated onset of non-depolarizing neuromuscular blocking drugs: pancuronium, atracurium and vecuronium. A comparison with succinylcholine.
    Mehta MP; Sokoll MD; Gergis SD
    Eur J Anaesthesiol; 1988 Jan; 5(1):15-21. PubMed ID: 2897912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of non-depolarizing neuromuscular blockers in patients with aortic valve disease.
    Sethna DH; Starr NJ; Estafanous FG
    Can J Anaesth; 1987 Nov; 34(6):582-8. PubMed ID: 2890442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine.
    Gramstad L
    Br J Anaesth; 1987 Aug; 59(8):995-1003. PubMed ID: 2888477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium.
    Berg H; Roed J; Viby-Mogensen J; Mortensen CR; Engbaek J; Skovgaard LT; Krintel JJ
    Acta Anaesthesiol Scand; 1997 Oct; 41(9):1095-1103. PubMed ID: 9366929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of the neuromuscular blocking agents.
    Larijani GE; Gratz I; Silverberg M; Jacobi AG
    DICP; 1991 Jan; 25(1):54-64. PubMed ID: 1672571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Newly developed muscle relaxants].
    Fukushima K
    Masui; 1997 Nov; 46 Suppl():S200-4. PubMed ID: 9508579
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuromuscular blocking agents.
    Hildebrand SV
    Vet Clin North Am Small Anim Pract; 1992 Mar; 22(2):341-7. PubMed ID: 1350124
    [No Abstract]   [Full Text] [Related]  

  • 17. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
    Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of calcium channel blockers with non-depolarising muscle relaxants in vitro.
    Sekerci S; Tulunay M
    Anaesthesia; 1996 Feb; 51(2):140-4. PubMed ID: 8779369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative neuromuscular function in pediatric day-care patients.
    Baxter MR; Bevan JC; Samuel J; Donati F; Bevan DR
    Anesth Analg; 1991 Apr; 72(4):504-8. PubMed ID: 1672489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic effects of vecuronium, pancuronium and atracurium in patients with coronary artery disease.
    Ferres CJ; Carson IW; Lyons SM; Orr IA; Patterson CC; Clarke RS
    Br J Anaesth; 1987 Mar; 59(3):305-11. PubMed ID: 2881568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.